These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 30606761)

  • 1. Antibody Dependent Enhancement of
    Wang-Lin SX; Olson R; Beanan JM; MacDonald U; Russo TA; Balthasar JP
    J Pharmacol Exp Ther; 2019 Mar; 368(3):475-489. PubMed ID: 30606761
    [No Abstract]   [Full Text] [Related]  

  • 2. The Capsular Polysaccharide of Acinetobacter baumannii Is an Obstacle for Therapeutic Passive Immunization Strategies.
    Wang-Lin SX; Olson R; Beanan JM; MacDonald U; Balthasar JP; Russo TA
    Infect Immun; 2017 Dec; 85(12):. PubMed ID: 28947651
    [No Abstract]   [Full Text] [Related]  

  • 3. The K1 capsular polysaccharide from Acinetobacter baumannii is a potential therapeutic target via passive immunization.
    Russo TA; Beanan JM; Olson R; MacDonald U; Cox AD; St Michael F; Vinogradov EV; Spellberg B; Luke-Marshall NR; Campagnari AA
    Infect Immun; 2013 Mar; 81(3):915-22. PubMed ID: 23297385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal immunization protects against Acinetobacter baumannii-associated pneumonia in mice.
    KuoLee R; Harris G; Yan H; Xu HH; Conlan WJ; Patel GB; Chen W
    Vaccine; 2015 Jan; 33(1):260-7. PubMed ID: 24699469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Hyr1 protein from the fungus Candida albicans is a cross kingdom immunotherapeutic target for Acinetobacter bacterial infection.
    Uppuluri P; Lin L; Alqarihi A; Luo G; Youssef EG; Alkhazraji S; Yount NY; Ibrahim BA; Bolaris MA; Edwards JE; Swidergall M; Filler SG; Yeaman MR; Ibrahim AS
    PLoS Pathog; 2018 May; 14(5):e1007056. PubMed ID: 29746596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoprotective potential of BamA, the outer membrane protein assembly factor, against MDR Acinetobacter baumannii.
    Singh R; Capalash N; Sharma P
    Sci Rep; 2017 Sep; 7(1):12411. PubMed ID: 28963492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of bacteriophage treatment against carbapenem-resistant Acinetobacter baumannii in Galleria mellonella larvae and a mouse model of acute pneumonia.
    Jeon J; Park JH; Yong D
    BMC Microbiol; 2019 Apr; 19(1):70. PubMed ID: 30940074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal Antibody Protects Against Acinetobacter baumannii Infection by Enhancing Bacterial Clearance and Evading Sepsis.
    Nielsen TB; Pantapalangkoor P; Luna BM; Bruhn KW; Yan J; Dekitani K; Hsieh S; Yeshoua B; Pascual B; Vinogradov E; Hujer KM; Domitrovic TN; Bonomo RA; Russo TA; Lesczcyniecka M; Schneider T; Spellberg B
    J Infect Dis; 2017 Aug; 216(4):489-501. PubMed ID: 28931235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic/pharmacodynamic evaluation of sulbactam against Acinetobacter baumannii in in vitro and murine thigh and lung infection models.
    Yokoyama Y; Matsumoto K; Ikawa K; Watanabe E; Shigemi A; Umezaki Y; Nakamura K; Ueno K; Morikawa N; Takeda Y
    Int J Antimicrob Agents; 2014 Jun; 43(6):547-52. PubMed ID: 24796218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active and passive immunization protects against lethal, extreme drug resistant-Acinetobacter baumannii infection.
    Luo G; Lin L; Ibrahim AS; Baquir B; Pantapalangkoor P; Bonomo RA; Doi Y; Adams MD; Russo TA; Spellberg B
    PLoS One; 2012; 7(1):e29446. PubMed ID: 22253723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum resistance, gallium nitrate tolerance and extrapulmonary dissemination are linked to heme consumption in a bacteremic strain of Acinetobacter baumannii.
    de Léséleuc L; Harris G; KuoLee R; Xu HH; Chen W
    Int J Med Microbiol; 2014 May; 304(3-4):360-9. PubMed ID: 24440358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A lethal pneumonia model of Acinetobacter baumannii: an investigation in immunocompetent mice.
    Zeng X; Gu H; Cheng Y; Jia KR; Liu D; Yuan Y; Chen ZF; Peng LS; Zou QM; Shi Y
    Clin Microbiol Infect; 2019 Apr; 25(4):516.e1-516.e4. PubMed ID: 30583061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mouse model of Acinetobacter baumannii-associated pneumonia using a clinically isolated hypervirulent strain.
    Harris G; Kuo Lee R; Lam CK; Kanzaki G; Patel GB; Xu HH; Chen W
    Antimicrob Agents Chemother; 2013 Aug; 57(8):3601-13. PubMed ID: 23689726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetic murine models for Acinetobacter baumannii infection.
    Luo G; Spellberg B; Gebremariam T; Bolaris M; Lee H; Fu Y; French SW; Ibrahim AS
    J Antimicrob Chemother; 2012 Jun; 67(6):1439-45. PubMed ID: 22389456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the trimeric autotransporter Ata as a vaccine candidate against Acinetobacter baumannii infections.
    Bentancor LV; Routray A; Bozkurt-Guzel C; Camacho-Peiro A; Pier GB; Maira-Litrán T
    Infect Immun; 2012 Oct; 80(10):3381-8. PubMed ID: 22825448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization against multidrug-resistant Acinetobacter baumannii effectively protects mice in both pneumonia and sepsis models.
    Huang W; Yao Y; Long Q; Yang X; Sun W; Liu C; Jin X; Li Y; Chu X; Chen B; Ma Y
    PLoS One; 2014; 9(6):e100727. PubMed ID: 24956279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative evaluation of intratracheal colistimethate sodium, imipenem, and meropenem in BALB/c mice with carbapenem-resistant Acinetobacter baumannii pneumonia.
    Tang HJ; Chuang YC; Ko WC; Chen CC; Shieh JM; Chen CH; Lee NY; Chiang SR
    Int J Infect Dis; 2012 Jan; 16(1):e34-40. PubMed ID: 22088863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective Capacity of Monoclonal Antibodies against Acinetobacter baumannii K9 Capsular Polysaccharide.
    Karatovskaya A; Rudenko N; Zamyatina A; Zvonarev A; Oleinikov V; Shpirt A; Perepelov A; Knirel Y; Brovko F
    Microbiol Spectr; 2023 Feb; 11(1):e0414122. PubMed ID: 36622150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoprotective potential of in silico predicted Acinetobacter baumannii outer membrane nuclease, NucAb.
    Garg N; Singh R; Shukla G; Capalash N; Sharma P
    Int J Med Microbiol; 2016 Jan; 306(1):1-9. PubMed ID: 26614015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. K2 Capsule Depolymerase Is Highly Stable, Is Refractory to Resistance, and Protects Larvae and Mice from Acinetobacter baumannii Sepsis.
    Oliveira H; Mendes A; Fraga AG; Ferreira A; Pimenta AI; Mil-Homens D; Fialho AM; Pedrosa J; Azeredo J
    Appl Environ Microbiol; 2019 Sep; 85(17):. PubMed ID: 31227554
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.